Rosa Maria Rodriguez Sarmiento

This inventor holds 29 USPTO granted patents and 4 published patent applications and 18 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Hoffmann-La Roche Inc.. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosa Maria Rodriguez Sarmiento. Retrieved from https://idiyas.com/inventor/rosa-maria-rodriguez-sarmiento

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 4)

% Patents Active = 17.2

EPO Patents = 18 (Patent Applications = 20)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 74(Granted Patents)

Company Filing History:

29 out of 5,027

Hoffmann-La Roche Inc.

patents

Years Active: 2002-2022

Loading Chart...

Areas of Expertise:

Phenoxytriazoles

Triazolopyridines

Piperidine Derivatives

PDE10A Inhibitors

Benzofurane Compounds

Dopamine D3 Receptors

Bicyclic Compounds

MAO-B Inhibitors

Isoxazolo Derivatives

Beta-Amino Acid Nitrile

Fluorobenzamides

Anellated Pyridine

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11319314 - Phenoxytriazoles (2022-05-03),

2. 10875854 - Triazolopyridines (2020-12-29),

3. 10604517 - Bridged piperidine derivatives (2020-03-31),

4. 9187455 - Substituted pyridazines as PDE10A inhibitors (2015-11-17),

5. 8921397 - Benzofurane-piperidine compounds (2014-12-30),

6. 8877778 - Benzofurane compounds (2014-11-04),

7. 8829029 - [object Object] (2014-09-09),

8. 8722683 - Benzodioxole piperazine compounds (2014-05-13),

9. 8598357 - Benzodioxole piperidine compounds (2013-12-03),

10. 8586579 - Anellated pyridine compounds (2013-11-19),

11. 8470828 - Anellated pyridine compounds (2013-06-25),

12. 8097637 - Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors (2012-01-17),

13. 8039490 - Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors (2011-10-18),

14. 7939535 - Benzo[D]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors (2011-05-10),

15. 7858630 - [object Object] (2010-12-28),

Title: Innovations and Contributions of Rosa Maria Rodriguez Sarmiento in Pharmaceutical Patents

Introduction: Rosa Maria Rodriguez Sarmiento is a distinguished inventor based in Basel, Switzerland, recognized for her significant contributions in the field of pharmaceuticals. With a remarkable portfolio of 29 patents, her work focuses primarily on innovative compounds that hold promise for treating various neurological disorders.

Latest Patents: Among her latest inventions, Rosa has developed compounds related to Phenoxytriazoles. This invention encompasses a compound represented by a specific formula where modifications include various heteroaryl groups and functional substitutes. These innovative compounds are anticipated to be effective in the treatment of conditions such as Alzheimer's disease, cerebral amyloid angiopathy, and multi-infarct dementia. Additionally, she has also filed patents related to Triazolopyridines, further expanding her impact within the pharmaceutical field.

Career Highlights: Rosa Maria Rodriguez Sarmiento is currently associated with Hoffmann-La Roche Inc., a prominent player in the pharmaceutical industry. Her work there involves pioneering research and development aimed at creating new therapeutic solutions that can address complex diseases affecting the brain.

Collaborations: Throughout her career, Rosa has collaborated with esteemed colleagues, including Andrew William Thomas and Rene Wyler. These partnerships reflect her commitment to advancing science through teamwork and innovation in research.

Conclusion: With her extensive patent portfolio and collaborative spirit, Rosa Maria Rodriguez Sarmiento exemplifies the role of inventors in driving innovation in the pharmaceutical industry. Her contributions are not only paving the way for novel treatments but also inspiring future generations of inventors in the field of medicine.

Profile summary based on public USPTO records.